A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
A. Glasgow (Belfast, United Kingdom)
Source: Lung Science Conference 2015
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: